Hypokalemia following rapid titration of quetiapine treatment

Journal of Clinical Psychiatry

Volumn 69, Issue 1, 2008, Pages 165-166

  Lin, Yu Chung ^a   Chen, Hao Zong ^b   Chang, Ta Jen ^a   Lane, Hsien Yuan ^c  

^a Jianan Mental Hospital   (Taiwan)

^b Chia yi Hospital   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM; QUETIAPINE;

ADULT; CASE REPORT; DROWSINESS; DRUG DOSE TITRATION; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; HUMAN; HYPOKALEMIA; INTENSIVE CARE; LABORATORY TEST; LETTER; MALE; MONOTHERAPY; PRIORITY JOURNAL; SCHIZOPHRENIA; SCORING SYSTEM; SUICIDE ATTEMPT;

EID: 39549096227     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v69n0122e     Document Type: Letter

References (18)

1. Lao HY. Antipsychotic drugs and hypokalemia. Zhonghua Shen Jing Jing Shen Ke Za Zhi 1991;24:75-76
2. Song SY. Cardiotoxicity of antipsychotic drugs: abnormal ECG in 1266 cases. Zhonghua Shen Jing Jing Shen Ke Za Zhi 1989;22:77-79
3. Aunsholt NA. Prolonged Q-T interval and hypokalemia caused by haloperidol. Acta Psychiatr Scand 1989;79:411-412
4. Malik AR, Wolf PK, Ravasia S. Hypokalemia from risperidone and quetiapine overdose. Can J Psychiatry 2005;50:76
5. Welch R, Chue P. Antipsychotic agents and QT changes. J Psychiatry Neurosci 2000;25:154-160
6. Naranjo CA, Busto U, Sellers EM. Difficulties in assessing adverse drug reactions in clinical trials. Prog Neuropsychopharmacol Biol Psychiatry 1982;6:651-657
7. Fraioli S, Cioli I, Nencini P. Amphetamine reinstates polydipsia induced by chronic exposure to quinpirole, a dopaminergic D2 agonist, in rats. Behav Brain Res 1997;89:199-215
8. Bersani G, Pesaresi L, Orlandi V, et al. Atypical antipsychotics and polydipsia: a cause or a treatment? Hum Psychopharmacol 2007;22:103-107
9. Lin KM, Poland RE, Lau JK, et al. Haloperidol and prolactin concentrations in Asians and Caucasians. J Clin Psychopharmacol 1988;8:195-201
10. Lin KM, Poland RE, Nuccio I, et al. A longitudinal assessment of haloperidol doses and serum concentrations in Asian and Caucasian schizophrenic patients. Am J Psychiatry 1989;146:1307-1311
11. Lane HY, Chang YC, Chang WH, et al. Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics. J Clin Psychiatry 1999;60:36-40
12. Lane HY, Chiu WC, Chou JCY, et al. Risperidone in acutely exacerbated schizophrenia: dosing strategies and plasma levels. J Clin Psychiatry 2000;61:209-214
13. Jann MW, Chang WH, Lam YW, et al. Comparison of haloperidol and reduced haloperidol plasma levels in four different ethnic populations. Prog Neuropsychopharmacol Biol Psychiatry 1992;16:193-202
14. Ereshefsky L. Pharmacologic and pharmacokinetic considerations in choosing an antipsychotic. J Clin Psychiatry 1999;60(suppl 10):20-30
15. DeVane CL, Nemeroff CB. Clinical pharmacokinetics of quetiapine: an atypical antipsychotic. Clin Pharmacokinet 2001;40:509-522
16. Shimada T, Yamazaki H, Mimura M, et al. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994;270:414-423
17. Lane HY, Lee CC, Chang YC, et al. Effects of dopamine D2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function. Int J Neuropsychopharmacol 2004;7:461-470
18. Bechdolf A, Ruhrmann S, Wagner M, et al. Interventions in the initial prodromal states of psychosis in Germany: concept and recruitment. Br J Psychiatry Suppl 2005;48:S45-S48